KCM
BLUE

Kingdon Capital Management’s bluebird bio BLUE Stock Holding History

Kingdon Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,088
Closed -$4.83M – 134
2015
Q1 		$4.83M Buy
+3,088
New +$4.07M 0.2% 115

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Kingdon Capital Management's BLUE Position: Q3 2015 in Review

Kingdon Capital Management sold out of bluebird bio (BLUE) in Q3 2015, closing a stake of 11,473 shares — an estimated $25M sold.

Kingdon Capital Management first reported a position in BLUE in Q2 2014 and held it in 5 quarters. The position peaked at $25M in Q2 2015. 192 funds tracked by Wall St. Rank hold BLUE as of Q3 2015.

  • Kingdon Capital Management reported no remaining bluebird bio position as of Q3 2015 after selling out during the quarter.
  • Kingdon Capital Management sold 11,473 bluebird bio shares in Q3 2015, an estimated $25M.
  • Kingdon Capital Management first reported a position in bluebird bio in Q2 2014 and held it in 5 quarters.
  • Kingdon Capital Management's bluebird bio position peaked at $25M in Q2 2015.
  • 192 funds tracked by Wall St. Rank held bluebird bio as of Q3 2015.

Based on Kingdon Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.